Loading
Zyflamend is a commercial blend of ten herbs marketed for healthy inflammation and sometimes used by men with prostate cancer. It slowed prostate cancer in animals, but in people there is only a small safety trial in a precancerous prostate condition and a few case reports, which do not show it works.
Zyflamend is a dietary supplement containing ten herbal extracts, marketed for a healthy inflammation response and heart and joint function. Memorial Sloan Kettering's About Herbs summary describes antiproliferative effects in oral, pancreatic, melanoma and bladder cancer cells and slowed growth of hormone-sensitive and insensitive prostate cancer in an animal model. Human data are limited: a phase I trial in men with prostatic intraepithelial neoplasia found no serious adverse events and falls in C-reactive protein and NF-kappa-B, and a few cases of response to combination regimens including Zyflamend have been described in castration-resistant prostate cancer. MSK states more studies are warranted. Reported side effects are a bad taste, heartburn and diarrhoea. In preclinical work it added to the effects of gemcitabine, paclitaxel, doxorubicin and bicalutamide, and with ten herbs it can potentially interact with prescription drugs.
A mixture including turmeric, ginger, green tea, holy basil and others, with COX-inhibiting and anti-inflammatory constituents in laboratory models.
Query for this technology: (TITLE:"Zyflamend" OR ABSTRACT:"Zyflamend" OR TITLE:"ten-herb formula" OR ABSTRACT:"ten-herb formula") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Zyflamend (ten-herb formula), not a curated reading list.
Shares Curcumin and turmeric, Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Shares Beta-elemene, Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Shares Beta-elemene, Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Shares Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies, Prostate cancer and the tags complementary, supportive-care.
Shares Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies, Doxorubicin and the tags complementary, supportive-care.
Shares Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies, Paclitaxel / nab-paclitaxel and the tags complementary, supportive-care.
Shares Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Doxorubicin, Paclitaxel / nab-paclitaxel and the tags complementary, supportive-care.
Shares Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/